Tamoxifen is still a major force in breast cancer treatment

By Dr Richard Berks, Research Information Officer.

The difference breast cancer research funding makes

By Katie Goates, Research Information Officer.

Ten years ago Breast Cancer Campaign funded Professor Nazneen Rahman to help her find new genes that could increase a person’s risk of developing breast cancer. Her team went on to discover that faults in the genes ATM, BRIP1 and PALB2 can modestly increase the risk of breast cancer.

The 'Angelina Jolie' effect on breast cancer and BRCA

The 'Angelina Jolie' effect on breast cancer and BRCA

Yesterday was a crazy day as news broke that Angelina Jolie has had a double

Intensity Modulated Radiation Therapy (IMRT) shows better cosmetic results than standard 2D radiotherapy

Our Research Information Officer Katie Goates reports on findings from a radiotherapy conference in Geneva: '

Tags: 

Pages

Share this

Get In Touch

Address: Clifton Centre, 110 Clifton Street, London EC2A 4HT

Main Switchboard: 020 7749 4114

Media Enquiries (Office Hours):
020 7749 4115

Media Enquiries (Out of Hours):
07436 107914

Email: info@breastcancercampaign.org

Websites:

breastcancercampaign.org

wearitpink.co.uk

breastcancertissuebank.org

grants.breastcancercampaign.org

FRSB logo